echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Acta Neuropathologica: The heterogeneity of alpha-synuclein fibril activity in patients with Lewy body dementia is related to disease phenotype

    Acta Neuropathologica: The heterogeneity of alpha-synuclein fibril activity in patients with Lewy body dementia is related to disease phenotype

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The aggregation of alpha-synuclein is a typical pathology of synucleinopathies, including Parkinson's disease (PD), Lewy body dementia (DLB) and multiple system atrophy (MSA).


    The aggregation of α-synuclein is a typical pathology of synucleinopathies, including Parkinson's disease (PD), Lewy body dementia (DLB) and multiple system atrophy (MSA).


    Analysis aimed at identifying the conformation of template fibers present in tissues and biological fluids includes protein misfolding cyclic amplification (PMCA) and related real-time shock-induced transformation (RT-QuIC) methods.


    Recent studies have highlighted the structural variation associated with α-synuclein aggregates in the patient population.


    The α-synuclein fibril activity in the cerebral cortex extract of DLB ​​patients is correlated with the CSF activity of the matched ventricle.


    The results of this article emphasize the previously unknown wide heterogeneity of fiber template activity in DLB, which may be related to the disease phenotype.


    The extensive heterogeneity of fiber template activity in DLB may be related to the disease phenotype.


    Sokratian, A.
    , Ziaee, J.
    , Kelly, K.
    et al.
    springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener">Heterogeneity in springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener"> Heterogeneity in  springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener">α α springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener">-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia.
    springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener"> -synuclein fibril activity correlates to disease phenotypes in Lewy body dementia.
    Acta Neuropathol 141,  547–564 (2021).
    Leave a message here springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener">springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener">springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener">springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener"> springer.
    com/article/10.
    1007/s00401-021-02288-1" target="_blank" rel="noopener"> 
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.